主动脉介入术后腔内再干预的结局分析
基于GREAT注册数据库3974例EVAR患者,比较再干预(196例,4.9%)与初次EVAR的结局。再干预组2年全因死亡(21.4% vs 12.5%)和主动脉相关死亡(4.6% vs 1%)均更高;既往开放手术后行再干预者全因死亡更高(32.7% vs 17.7%)。
要点
- 主动脉腔内再干预2年全因和主动脉相关死亡均高于初次EVAR
- 既往开放主动脉术后再干预的全因死亡高于既往EVAR后再干预
- 既往开放手术、肾功能不全、切开入路是死亡预测因素
核心结论
- 主动脉病理的腔内再干预与高于初次EVAR的死亡率相关。
- 既往开放主动脉手术后再干预的死亡率高于既往EVAR后再干预。
研究设计与样本
- 基于GREAT全球注册数据库的回顾性队列分析。
- 共纳入3974例接受EVAR且有随访数据的患者,其中196例(4.9%)为再干预。
- 再干预中49例既往开放主动脉手术,147例既往EVAR。
主要发现
- 再干预组2年全因死亡21.4% vs 初次EVAR组12.5%(P = .0003)。
- 再干预组2年主动脉相关死亡4.6% vs 初次EVAR组1%(P < .0001)。
- 既往开放手术后再干预2年全因死亡32.7% vs 既往EVAR后再干预17.7%(P = .0.03)。
- 既往EVAR后再干预2年内内漏率有更高趋势(13.6% vs 4.1%;P = .07),干预发生率无差异(12.2% vs 17.7%;P = .37)。
- 再干预组年龄更大(75.3岁 vs 73.3岁;P = .0005),仅使用股动脉入路更多(95.8% vs 90.3%;P < .0001),主动脉分支血管手术更多(32.3% vs 13.3%;P < .0001)。
关键数值与推荐
- 死亡预测因素包括既往开放主动脉手术、肾功能不全、使用切开入路。
- 主动脉相关死亡多变量预测因素包括再干预、肾功能不全、慢性阻塞性肺疾病、低体重指数、主动脉直径增加、使用肱动脉或其他动脉入路。
临床怎么用
- 对主动脉腔内再干预患者应识别高危因素并加强术后监测。
- 既往开放主动脉手术后再干预者死亡风险更高,需更谨慎评估。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular reinterventions are often performed after previous open or endovascular aortic procedures. We used the GREAT (Global Registry for Endovascular Aortic Treatment) database to compare the outcomes between these groups. We also compared reintervention of any type with a group of patients who had undergone primary endovascular abdominal aortic aneurysm repair (EVAR). METHODS: All patients enrolled in GREAT were grouped according to a previous EVAR or open abdominal aortic procedure (OAP). Univariate analysis was performed using the χ2, Wilcoxon rank sum, and Fisher exact tests. Cox proportional analysis was used to test the predictors for all-cause and aorta-related mortality. RESULTS: A total of 3974 subjects who had undergone EVAR with follow-up data available were included in the GREAT. Of the 3974 procedures, 196 (4.9%) were reinterventions (49 after OAP and 147 after previous EVAR). Reintervention after previous EVAR showed a trend toward a greater endoleak rate through 2 years (13.6% vs 4.1%; P = .07), although no difference was found in the occurrence of the intervention (12.2% vs 17.7%; P = .37). Reintervention after OAP resulted in higher all-cause mortality through 2 years of follow-up (32.7% vs 17.7%; P = .0.03). The predictors of mortality included prior OAP, renal insufficiency, and the use of cutdown for access. Compared with the patients who had undergone primary endovascular repair, patients in the reintervention cohort were older (75.3 years vs 73.3 years; P = .0005), had had only femoral artery access used (95.8% vs 90.3%; P < .0001), and were more likely to have undergone aortic branch vessel procedures (32.3% vs 13.3%; P < .0001). Both all-cause and aorta-related mortality through 2 years was higher in the reintervention group than in the primary EVAR group (21.4% vs 12.5% [P = .0003; and 4.6% vs 1% [P < .0001], respectively). On multivariate analysis, the predictors of aortic-related mortality included reintervention, renal insufficiency, chronic obstructive pulmonary disease, underweight body mass index, increasing aortic diameter, and the use of brachial artery or other arterial access sites. CONCLUSIONS: Endovascular reintervention for aortic pathology was associated with higher mortality than was primary EVAR. Reinterventions after prior OAPs were associated with higher mortality than were prior EVARs.
引用
- Kainth AS, Sura TA, Williams MS, et al. Outcomes after endovascular reintervention for aortic interventions. J Vasc Surg. 2021. PMID: 34592379. doi:10.1016/j.jvs.2021.08.090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。